Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Arrive AI Inc.ARAI · Entity 7895 | Director | October 02, 2026 | October 09, 2026 |
| CVS HEALTH CorpCVS · Entity 2884 | Director | May 14, 2026 | May 15, 2026 |
| Elevance Health, Inc.ELV · Entity 2934 | EVP & Chief Financial Officer | March 01, 2023 | March 03, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Arrive AI Inc.
Report date October 02, 2026 · Filed October 09, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock AwardSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 172,811 |
Reported balance
After 2026-10-02 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-10-02 · Grant · Acquired 172,811 · Balance 172,811 F1: Restricted Stock Units (RSUs) were granted on October 2, 2026, which vest on September 30, 2027. The RSUs have been issued pursuant to the Company's 2023 Equity Incentive Plan. F2: The RSUs do not expire, they either vest or are canceled prior to the vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted Stock Units (RSUs) were granted on October 2, 2026, which vest on September 30, 2027. The RSUs have been issued pursuant to the Company's 2023 Equity Incentive Plan.
F2: The RSUs do not expire, they either vest or are canceled prior to the vesting date.
CVS HEALTH Corp
Report date May 14, 2026 · Filed May 15, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Deferred Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 1,447.5039 |
Reported balance
After 2026-05-14 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-05-14 · Grant · Acquired 1,447.5039 · Balance 1,447.5039 F1: Consists of deferred stock units issued for deferral of a semi-annual retainer in connection with the Issuer's non-employee director compensation policy, valued at the market price, pursuant to the Issuer's 2017 Incentive Compensation Plan. F2: Consists of deferred stock units, each to be converted into one share of common stock and issued in the future, as elected by the Reporting Person. |
Filing footnotes · ownership attribution and instrument terms
F1: Consists of deferred stock units issued for deferral of a semi-annual retainer in connection with the Issuer's non-employee director compensation policy, valued at the market price, pursuant to the Issuer's 2017 Incentive Compensation Plan.
F2: Consists of deferred stock units, each to be converted into one share of common stock and issued in the future, as elected by the Reporting Person.
Elevance Health, Inc.
Report date March 01, 2023 · Filed March 03, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 63,725 |
Ending reported balance
After 2023-03-02 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2023-03-01 · Tax withholding · Disposed 587 · Balance 55,594 F1: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Row 2 · 2023-03-01 · Grant · Acquired 3,065 · Balance 58,659 F2: Represents restricted share units. Restrictions lapse as follows: 1,021 shares on 3/1/2024, and 1,022 shares each on 3/1/2025 and 3/1/2026. Row 3 · 2023-03-01 · Grant · Acquired 9,716 · Balance 68,375 F3: Represents performance based restricted share units. Restrictions lapse on 3/2/2023. Row 4 · 2023-03-02 · Tax withholding · Disposed 4,650 · Balance 63,725 F1: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $469.03 · Expires 2033-03-01 | Direct | 11,782 |
Reported balance
After 2023-03-01 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2023-03-01 · Grant · Acquired 11,782 · Balance 11,782 F4: The option represents a right to purchase a total of 11,782 shares, and is exercisable in two installments of 3,927 shares each and one installment of 3,928 shares, beginning on 3/1/2024, which is the one-year anniversary of the option grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
F2: Represents restricted share units. Restrictions lapse as follows: 1,021 shares on 3/1/2024, and 1,022 shares each on 3/1/2025 and 3/1/2026.
F3: Represents performance based restricted share units. Restrictions lapse on 3/2/2023.
F4: The option represents a right to purchase a total of 11,782 shares, and is exercisable in two installments of 3,927 shares each and one installment of 3,928 shares, beginning on 3/1/2024, which is the one-year anniversary of the option grant date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 01, 2019 Filed Mar 5, 2019 21:08 UTC | Elevance Health, Inc. ANTM · Entity 2934 | GrantCommon Stock | 4,033 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-009899 · form4.xml · nonDerivative · entry 4 Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,056 F4 · shares: Represents performance based restricted share units. Restrictions lapse on 6/1/19. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:08 UTC | Elevance Health, Inc. ANTM · Entity 2934 | GrantCommon Stock | 2,641 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-009899 · form4.xml · nonDerivative · entry 3 Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,023 F3 · shares: Represents restricted share units. Restrictions lapse as follows: 880 shares each on 3/1/2020 and 3/1/2021, and 881 on 3/1/2022. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:08 UTC | Elevance Health, Inc. ANTM · Entity 2934 | GrantCommon Stock | 2,940 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-009899 · form4.xml · nonDerivative · entry 2 Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,382 F2 · shares: Represents performance based restricted share units. Restrictions lapse on 3/1/19. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:08 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Tax withholdingCommon Stock | 2,217 | $307.68 | $682,126.56 |
DisclosureSEC source: 0001127602-19-009899 · form4.xml · nonDerivative · entry 1 Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,442 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| June 01, 2018 Filed Jun 5, 2018 20:22 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Tax withholdingCommon Stock | 275 | $221.50 | $60,912.50 |
DisclosureSEC source: 0001127602-18-020019 · form4.xml · nonDerivative · entry 1 Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,659 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| March 05, 2018 Filed Mar 7, 2018 21:35 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 4,036 | $0.00 Strike: $132.51 | $0.00 |
DisclosureSEC source: 0001127602-18-010570 · form4.xml · derivative · entry 12 Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,038 Underlying: Common Stock · 4,036 shares Expires 2026-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: The option represents a right to purchase a total of 8,074 shares, is exercisable in two installments of 1,345 shares each and four installments of 1,346 shares each, beginning on December 1, 2016, which is the six-month anniversary of the option grant date. Read SEC document |
| March 05, 2018 Filed Mar 7, 2018 21:35 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 6,466 | $0.00 Strike: $89.44 | $0.00 |
DisclosureSEC source: 0001127602-18-010570 · form4.xml · derivative · entry 11 Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,466 shares Expires 2021-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The option, representing a right to purchase a total of 9,698 shares, is exercisable in four semi-annual installments of 1,616 shares each and two semi-annual installments of 1,617 shares each beginning on September 3, 2014, which is the six-month anniversary of the date on which the option was granted. Read SEC document |
| March 05, 2018 Filed Mar 7, 2018 21:35 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 3,921 | $0.00 Strike: $131.80 | $0.00 |
DisclosureSEC source: 0001127602-18-010570 · form4.xml · derivative · entry 10 Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,962 Underlying: Common Stock · 3,921 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option, representing a right to purchase a total of 5,883 shares, is exercisable in three semi-annual installments of 980 shares each and three semi-annual installments of 981 shares each beginning on September 1, 2016, which is the six-month anniversary of the date on which the option was granted. Read SEC document |
| March 05, 2018 Filed Mar 7, 2018 21:35 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 3,948 | $0.00 Strike: $61.88 | $0.00 |
DisclosureSEC source: 0001127602-18-010570 · form4.xml · derivative · entry 9 Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,948 shares Expires 2020-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option, representing a right to purchase a total of 11,843 shares, is exercisable in one installment of 1,973 shares and five semi-annual installments of 1,974 shares each beginning on September 1, 2013, which is the six-month anniversary of the date on which the option was granted. Read SEC document |
| March 05, 2018 Filed Mar 7, 2018 21:35 UTC | Elevance Health, Inc. ANTM · Entity 2934 | SaleCommon Stock | 4,100 | $231.29 | $948,289.00 |
DisclosureSEC source: 0001127602-18-010570 · form4.xml · nonDerivative · entry 8 Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,934 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2017. F4 · price: This transaction was executed in multiple trades at prices ranging from $231.01 to $231.83. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 05, 2018 Filed Mar 7, 2018 21:35 UTC | Elevance Health, Inc. ANTM · Entity 2934 | SaleCommon Stock | 5,372 | $230.44 | $1,237,923.68 |
DisclosureSEC source: 0001127602-18-010570 · form4.xml · nonDerivative · entry 7 Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,034 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2017. F3 · price: This transaction was executed in multiple trades at prices ranging from $230.00 to $230.97. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 05, 2018 Filed Mar 7, 2018 21:35 UTC | Elevance Health, Inc. ANTM · Entity 2934 | SaleCommon Stock | 15,104 | $229.19 | $3,461,685.76 |
DisclosureSEC source: 0001127602-18-010570 · form4.xml · nonDerivative · entry 6 Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,406 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2017. F2 · price: This transaction was executed in multiple trades at prices ranging from $229.00 to $229.98. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 05, 2018 Filed Mar 7, 2018 21:35 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Exercise / conversionCommon Stock | 4,036 | $132.51 | $534,810.36 |
DisclosureSEC source: 0001127602-18-010570 · form4.xml · nonDerivative · entry 5 Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,510 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 05, 2018 Filed Mar 7, 2018 21:35 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Exercise / conversionCommon Stock | 6,466 | $89.44 | $578,319.04 |
DisclosureSEC source: 0001127602-18-010570 · form4.xml · nonDerivative · entry 4 Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,474 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 05, 2018 Filed Mar 7, 2018 21:35 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Exercise / conversionCommon Stock | 3,921 | $131.80 | $516,787.80 |
DisclosureSEC source: 0001127602-18-010570 · form4.xml · nonDerivative · entry 3 Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,008 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 05, 2018 Filed Mar 7, 2018 21:35 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Exercise / conversionCommon Stock | 3,948 | $61.88 | $244,302.24 |
DisclosureSEC source: 0001127602-18-010570 · form4.xml · nonDerivative · entry 2 Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,087 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 05, 2018 Filed Mar 7, 2018 21:35 UTC | Elevance Health, Inc. ANTM · Entity 2934 | GiftCommon Stock | 2,448 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-010570 · form4.xml · nonDerivative · entry 1 Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,139 Read SEC document |
| March 02, 2018 Filed Mar 5, 2018 21:43 UTC | Elevance Health, Inc. ANTM · Entity 2934 | GrantCommon Stock | 4,211 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-010095 · form4.xml · nonDerivative · entry 4 Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,587 F3 · shares: Represents performance based restricted share units. Restrictions lapsed on 3/2/18. Read SEC document |
| March 02, 2018 Filed Mar 5, 2018 21:43 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Tax withholdingCommon Stock | 1,688 | $233.08 | $393,439.04 |
DisclosureSEC source: 0001127602-18-010095 · form4.xml · nonDerivative · entry 3 Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,376 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 21:43 UTC | Elevance Health, Inc. ANTM · Entity 2934 | GrantEmployee Stock Option (Right to Buy) · Derivative | 14,761 | $0.00 Strike: $232.04 | $0.00 |
DisclosureSEC source: 0001127602-18-010095 · form4.xml · derivative · entry 5 Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,761 Underlying: Common Stock · 14,761 shares Expires 2028-03-01 F4 · derivative.exercise_date: The option represents a right to purchase a total of 14,761 shares, and is exercisable in six semi-annual installments, with five installments of 2,460 shares each and one installment of 2,461 shares, beginning on September 1, 2018, which is the six-month anniversary of the option grant date. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 21:43 UTC | Elevance Health, Inc. ANTM · Entity 2934 | GrantCommon Stock | 3,502 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-010095 · form4.xml · nonDerivative · entry 2 Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,064 F2 · shares: Represents restricted share units. Restrictions lapse as follows: 1,167 shares each on 3/1/2019 and 3/1/2020, and 1,168 on 3/1/2021. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 21:43 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Tax withholdingCommon Stock | 660 | $232.04 | $153,146.40 |
DisclosureSEC source: 0001127602-18-010095 · form4.xml · nonDerivative · entry 1 Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,562 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 20:03 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Tax withholdingCommon Stock | 291 | $187.69 | $54,617.79 |
DisclosureSEC source: 0001127602-17-020299 · form4.xml · nonDerivative · entry 2 Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,222 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| May 08, 2017 Filed Jun 2, 2017 20:03 UTC | Elevance Health, Inc. ANTM · Entity 2934 | GiftCommon Stock | 3,211 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-020299 · form4.xml · nonDerivative · entry 1 Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,513 Read SEC document |
| March 03, 2017 Filed Mar 7, 2017 21:17 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Tax withholdingCommon Stock | 977 | $166.00 | $162,182.00 |
DisclosureSEC source: 0001127602-17-010578 · form4.xml · nonDerivative · entry 1 Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,724 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| March 02, 2017 Filed Mar 3, 2017 21:18 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Tax withholdingCommon Stock | 129 | $165.97 | $21,410.13 |
DisclosureSEC source: 0001127602-17-010143 · form4.xml · nonDerivative · entry 3 Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,701 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 21:18 UTC | Elevance Health, Inc. ANTM · Entity 2934 | GrantEmployee Stock Option (Right to Buy) · Derivative | 19,908 | $0.00 Strike: $166.97 | $0.00 |
DisclosureSEC source: 0001127602-17-010143 · form4.xml · derivative · entry 4 Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,908 Underlying: Common Stock · 19,908 shares Expires 2027-03-01 F3 · derivative.exercise_date: The option represents a right to purchase a total of 19,908 shares, and is exercisable in six semi-annual installments of 3,318 shares each, beginning on September 1, 2017, which is the six-month anniversary of the option grant date. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 21:18 UTC | Elevance Health, Inc. ANTM · Entity 2934 | GrantCommon Stock | 4,867 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-010143 · form4.xml · nonDerivative · entry 2 Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,830 F2 · shares: Represents restricted share units. Restrictions lapse as follows: 1,622 shares each on 3/1/2018 and 3/1/2019, and 1,623 on 3/1/2020. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 21:18 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Tax withholdingCommon Stock | 165 | $166.97 | $27,550.05 |
DisclosureSEC source: 0001127602-17-010143 · form4.xml · nonDerivative · entry 1 Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,963 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.